Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

This observational study looks at the cost-effectiveness of two common types of diabetes medications — sulfonylureas and DPP-4 inhibitors — both used alongside metformin for type 2 diabetes. It reviews patient records to compare which combination gives better blood sugar control and fewer complications at lower cost. **You may be eligible if:** - You are 18 or older - You were newly diagnosed with type 2 diabetes within the past 2-5 years - You have been taking either a sulfonylurea or a DPP-4 inhibitor combined with metformin since your diagnosis - You are willing to provide written consent **You may NOT be eligible if:** - You are unwilling to participate or provide consent - You are on insulin or metformin alone since your diagnosis - You are taking other diabetes medications not in the sulfonylurea/DPP-4 category - You had diabetes-related complications at the time of diagnosis Talk to your doctor to see if this trial is right for you.